Last reviewed · How we verify
KM-001 1% cream 12 weeks treatment
KM-001 1% cream 12 weeks treatment is a Small molecule drug developed by Kamari Pharma Ltd. It is currently in Phase 1 development. Also known as: Cohort 1.
At a glance
| Generic name | KM-001 1% cream 12 weeks treatment |
|---|---|
| Also known as | Cohort 1 |
| Sponsor | Kamari Pharma Ltd |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- Assessment of KM-001 - Safety, Tolerability, and Efficacy in Patients With PPPK1 or PC (PHASE1)
- Study Designed to Evaluate Safety and Efficacy of 1% Topical Formulation of KM-001 on Type 1 Punctate Palmoplantar Keratoderma or Pachyonychia Congenita Diseases (PHASE1)
- KM-001 Cream for Treatment of Pruritus in Adult Patients With Lichen Simplex Chronicus (LSC) (PHASE1)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- KM-001 1% cream 12 weeks treatment CI brief — competitive landscape report
- KM-001 1% cream 12 weeks treatment updates RSS · CI watch RSS
- Kamari Pharma Ltd portfolio CI
Frequently asked questions about KM-001 1% cream 12 weeks treatment
What is KM-001 1% cream 12 weeks treatment?
KM-001 1% cream 12 weeks treatment is a Small molecule drug developed by Kamari Pharma Ltd.
Who makes KM-001 1% cream 12 weeks treatment?
KM-001 1% cream 12 weeks treatment is developed by Kamari Pharma Ltd (see full Kamari Pharma Ltd pipeline at /company/kamari-pharma-ltd).
Is KM-001 1% cream 12 weeks treatment also known as anything else?
KM-001 1% cream 12 weeks treatment is also known as Cohort 1.
What development phase is KM-001 1% cream 12 weeks treatment in?
KM-001 1% cream 12 weeks treatment is in Phase 1.
Related
- Manufacturer: Kamari Pharma Ltd — full pipeline
- Also known as: Cohort 1
- Compare: KM-001 1% cream 12 weeks treatment vs similar drugs
- Pricing: KM-001 1% cream 12 weeks treatment cost, discount & access